Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease
**Background:** Crohn’s disease (CD) treatments and associated adverse events (AEs) can be burdensome for patients. However, specific values which quantify the impact on health-related quality of life (HRQL) for economic evaluation are lacking. **Objectives:** This study aimed to elicit health util...
Saved in:
Main Authors: | Melany Worbes-Cerezo, Beenish Nafees, Andrew Lloyd, Katy Gallop, Imran Ladha, Cicely Kerr |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2019-03-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9685 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
by: Remo Panaccione, et al.
Published: (2011-01-01) -
Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01) -
Combination of Ciprofloxacin and Metronidazole in Severe Perianal Crohn’s Disease
by: MJ Solomon, et al.
Published: (1993-01-01) -
Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease
by: Haohang Su, et al.
Published: (2025-01-01) -
Prevalence Rates and an Evaluation of Reported Risk Factors for Osteonecrosis (Avascular Necrosis) in Crohn’s Disease
by: Hugh J Freeman, et al.
Published: (2000-01-01)